Evidence map›Paper›PMID 26205609›Full record

Trial reportHealth expectations : an international journal of public participation in health care and health policy2016

Disclosure of research results: a randomized study on GENEPSO-PS cohort participants.

Julien Mancini, Elodie Le Cozannet, Anne-Déborah Bouhnik, Noémie Resseguier, Christine Lasset, Emmanuelle Mouret-Fourme, Catherine Noguès, Claire Julian-Reynier

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Health expectations : an international journal of public participation in health care and health policy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03667417 (Genetic Predisposition to Breast and Ovarian Cancer), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03667417 recruitingnot on this map

Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

TypeobservationalSponsorInstitut Paoli-CalmettesRan1999 to 2028Enrolled5,000ConditionsBreast Cancers, Ovarian CancersArmsQuestionnaires
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julien ManciniAix Marseille Université, UMR_S912, IRD, SESSTIM, Marseille, France. julien.mancini@univ-amu.fr.
Elodie Le CozannetAix Marseille Université, UMR_S912, IRD, SESSTIM, Marseille, France.
Anne-Déborah BouhnikAix Marseille Université, UMR_S912, IRD, SESSTIM, Marseille, France.
Noémie ResseguierAix Marseille Université, UMR_S912, IRD, SESSTIM, Marseille, France.
Christine LassetCentre Léon Bérard, Lyon, France.
Emmanuelle Mouret-FourmeInstitut Curie, Hôpital René Huguenin, Saint-Cloud, France.
Catherine NoguèsInstitut Curie, Hôpital René Huguenin, Saint-Cloud, France.
Claire Julian-ReynierAix Marseille Université, UMR_S912, IRD, SESSTIM, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere exist no recommendations as to how aggregate research results should best be disclosed to long-term cohort participants.

objectiveTo study the impact of cohort results disclosure documents of various kinds on participants' satisfaction.

designRandomized study with a 2x2 factorial design. SETTING AND

participantsThe GENEPSO-PS cohort is used to study the psychosocial characteristics and preventive behaviour of both BRCA1/2 carriers and non-carriers; 235 participants wishing to receive 'information about the survey results' answered a self-administered questionnaire.

interventionsThe impact of providing the following items in addition to a leaflet about aggregate psychosocial research results was investigated (i) an up-to-date medical information sheet about BRCA1/2 genetic topics, (ii) a photograph with the names of the researchers.

main outcome measuresSatisfaction profiles drawn up using cluster analysis methods.

resultsProviding additional medical and/or research team information had no significant effect on satisfaction. The patients attributed to the 'poorly satisfied' group (n = 60, 25.5%) differed significantly from those in the 'highly satisfied' group (n = 51, 21.7%): they were younger [odds ratio (OR) = 0.96, 95% confidence interval (0.92-0.99), P = 0.028], less often had a daughter [OR = 4.87 (1.80-13.20), P = 0.002], had reached a higher educational level [OR = 2.94 (1.24-6.95), P = 0.014] and more frequently carried a BRCA1/2 mutation [OR = 2.73 (1.20-6.23), P = 0.017].

conclusionsThis original approach to disclosing research results to cohort participants was welcomed by most of the participants, but less by the more educated and by BRCA1/2 carriers. Although an easily understandable document is necessary, it might also be worth providing some participants with more in-depth information.

Indexed as

DisclosureHealth BehaviorPatient SatisfactionBreast NeoplasmsEducational StatusFemaleFranceGenes, BRCA1Genes, BRCA2Genetic Predisposition to DiseaseGenetic TestingHumansMaleMiddle AgedSurveys and QuestionnairesBRCA1/2cohortdisclosurerandomized controlled trialsresearch resultssatisfaction

Identifiers

PMID26205609
PMCPMC5054914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.